Bell Potter initiate coverage of SXE, page-9

Often that's very true (e.g. CSL, REH) but sometimes it's not (e.g. A2M, most online retailers after the pandemic, MND after the oil boom). I bought a bunch of A2M at $1 and I certainly don't regret the decision to sell almost all of them above $10.

Some stocks have the management and are in the right industry to be ongoing compounders but imho some are just in the right space at the right time until competition normalises margins.

SXE may have (much) further to run but ultimately I think it'll eventually settle into the MND category (who knows when that might be, I don't). In the interim I've banked some profits and will let the rest run.

Good luck and I'll be quite happy if SXE continues to perform as you expect.